[1]
|
Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249.
https://doi.org/10.3322/caac.21660
|
[2]
|
Liu, X.H., Liu, Z.L., Sun, M., et al. (2013) The Long Non-Coding RNA HOTAIR Indicates a Poor Prognosis and Promotes Metastasis in Non-Small Cell Lung Cancer. BMC Cancer, 13, Article No. 464.
https://doi.org/10.1186/1471-2407-13-464
|
[3]
|
Aberle, D.R., Adams, A.M., Berg, C.D., et al. (2011) Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening. The New England Journal of Medicine, 365, 395-409. https://doi.org/10.1056/NEJMoa1102873
|
[4]
|
Lee, S.H., Suh, I.B., Lee, E.J., et al. (2013) Relationships of Coagulation Factor XIII Activity with Cell-Type and Stage of Non-Small Cell Lung Cancer. Yonsei Medical Journal, 54, 1394-1399.
https://doi.org/10.3349/ymj.2013.54.6.1394
|
[5]
|
Song, G., Qin, T., Liu, H., et al. (2010) Quantitative Breath Analysis of Volatile Organic Compounds of Lung Cancer Patients. Lung Cancer (Amsterdam, Netherlands), 67, 227-231. https://doi.org/10.1016/j.lungcan.2009.03.029
|
[6]
|
Sedighzadeh, S.S., Khoshbin, A.P., Razi, S., et al. (2021) A Narrative Review of Tumor-Associated Macrophages in Lung Cancer: Regulation of Macrophage Polarization and Therapeutic Implications. Translational Lung Cancer Research, 10, 1889-1916. https://doi.org/10.21037/tlcr-20-1241
|
[7]
|
Cortez-Retamozo, V., Etzrodt, M., Newton, A., et al. (2012) Origins of Tumor-Associated Macrophages and Neutrophils. Proceedings of the National Academy of Sciences of the United States of America, 109, 2491-2496.
https://doi.org/10.1073/pnas.1113744109
|
[8]
|
Shand, F.H.W., Ueha, S., Otsuji, M., et al. (2014) Tracking of inter-tissue migration reveals the origins of tumor-infiltrating monocytes. Proceedings of the National Academy of Sciences of the United States of America, 111, 7771-7776. https://doi.org/10.1073/pnas.1402914111
|
[9]
|
Lewis, C.E., Harney, A.S. and Pollard, J.W. (2016) The Multifaceted Role of Perivascular Macrophages in Tumors. Cancer Cell, 30, 365. https://doi.org/10.1016/j.ccell.2016.07.009
|
[10]
|
Kowal, J., Kornete, M. and Joyce, J.A. (2019) Re-Education of Macrophages as a Therapeutic Strategy in Cancer. Immunotherapy, 11, 677-689. https://doi.org/10.2217/imt-2018-0156
|
[11]
|
Mills, C.D., Kincaid, K., Alt, J.M., et al. (2017) Pillars Article: M-1/M-2 Macrophages and the Th1/Th2 Paradigm. J. Immunol. 2000. 164: 6166-6173. Journal of Immunology (Balti-more, Md: 1950), 199, 2194-2201.
|
[12]
|
Biswas, S.K. and Mantovani, A. (2010) Macrophage Plasticity and Interaction with Lymphocyte Subsets: Cancer as a Paradigm. Nature Immunology, 11, 889-896. https://doi.org/10.1038/ni.1937
|
[13]
|
Duthie, M.S. and Reed, S.G. (2021) Skin Tests for the Detection of Mycobac-terial Infections: Achievements, Current Perspectives, and Implications for Other Diseases. Applied Microbiology and Bi-otechnology, 105, 503-508.
https://doi.org/10.1007/s00253-020-11062-4
|
[14]
|
Fleetwood, A.J., Lawrence, T., Hamilton, J.A., et al. (2007) Granulocyte-Macrophage Colony-Stimulating Factor (CSF) and Macrophage CSF-Dependent Macrophage Phenotypes Display Differences in Cytokine Profiles and Transcription Factor Activities: Implications for CSF Blockade in Inflam-mation. Journal of Immunology (Baltimore, Md: 1950), 178, 5245-5252. https://doi.org/10.4049/jimmunol.178.8.5245
|
[15]
|
Fujiwara, N. and Kobayashi, K. (2005) Macrophages in Inflam-mation. Current Drug Targets Inflammation and Allergy, 4, 281-286. https://doi.org/10.2174/1568010054022024
|
[16]
|
Porta, C., Riboldi, E., Ippolito, A., et al. (2015) Molecular and Epigenetic Basis of Macrophage Polarized Activation. Seminars in Immunology, 27, 237-248. https://doi.org/10.1016/j.smim.2015.10.003
|
[17]
|
Schultze, J.L. and Schmidt, S.V. (2015) Molecular Features of Macrophage Activation. Seminars in Immunology, 27, 416-423. https://doi.org/10.1016/j.smim.2016.03.009
|
[18]
|
Lewis, C.E. and Pollard, J.W. (2006) Distinct Role of Macro-phages in Different Tumor Microenvironments. Cancer Research, 66, 605-612. https://doi.org/10.1158/0008-5472.CAN-05-4005
|
[19]
|
De Sousa, J.R., Martins De Sousa, R.P., De Souza Aarao, T.L., et al. (2016) In Situ Expression of M2 Macrophage Subpopulation in Leprosy Skin Lesions. Acta Tropica, 157, 108-114. https://doi.org/10.1016/j.actatropica.2016.01.008
|
[20]
|
Griess, B., Mir, S., Datta, K., et al. (2020) Scav-enging Reactive Oxygen Species Selectively Inhibits M2 Macrophage Polarization and Their Pro-Tumorigenic Function in Part, via Stat3 Suppression. Free Radical Biology & Medicine, 147, 48-60. https://doi.org/10.1016/j.freeradbiomed.2019.12.018
|
[21]
|
Jayasingam, S.D., Citartan, M., Thang, T.H., et al. (2019) Evaluating the Polarization of Tumor-Associated Macrophages into M1 and M2 Phenotypes in Human Cancer Tissue: Technicalities and Challenges in Routine Clinical Practice. Frontiers in Oncology, 9, 1512. https://doi.org/10.3389/fonc.2019.01512
|
[22]
|
Zhang, Q., Huang, F., Yaom Y., et al. (2019) Interaction of Trans-forming Growth Factor-β-Smads/microRNA-362-3p/ CD82 Mediated by M2 Macrophages Promotes the Process of Ep-ithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells. Cancer Science, 110, 2507-2519. https://doi.org/10.1111/cas.14101
|
[23]
|
Denardo, D.G. and Ruffell, B. (2019) Macrophages as Regulators of Tu-mour Immunity and Immunotherapy. Nature Reviews Immunology, 19, 369-382. https://doi.org/10.1038/s41577-019-0127-6
|
[24]
|
Zhang, M., He, Y., Sun, X., et al. (2014) A High M1/M2 Ratio of Tumor-Associated Macrophages Is Associated with Extended Survival in Ovarian Cancer Patients. Journal of Ovarian Research, 7, Article No. 19.
https://doi.org/10.1186/1757-2215-7-19
|
[25]
|
Takeuchi, H., Tanaka, M., Tanaka, A., et al. (2016) Predominance of M2-Polarized Macrophages in Bladder Cancer Affects Angiogenesis, Tumor Grade and Invasiveness. Oncology Letters, 11, 3403-3408.
https://doi.org/10.3892/ol.2016.4392
|
[26]
|
Singhal, S., Stadanlick, J., Annunziata, M.J., et al. (2019) Human Tu-mor-Associated Monocytes/Macrophages and Their Regulation of T Cell Responses in Early-Stage Lung Cancer. Science Translational Medicine, 11, eaat1500,
https://doi.org/10.1126/scitranslmed.aat1500
|
[27]
|
Chong, B.F., Tseng, L.C., Hosler, G.A., et al. (2015) A Subset of CD163+ Macrophages Displays Mixed Polarizations in Discoid Lupus Skin. Arthritis Research & Therapy, 17, Arti-cle No. 324. https://doi.org/10.1186/s13075-015-0839-3
|
[28]
|
Elliott, L.A., Doherty, G.A., Sheahan, K., et al. (2017) Human Tumor-Infiltrating Myeloid Cells: Phenotypic and Functional Diversity. Frontiers in Immunology, 8, Article No. 86. https://doi.org/10.3389/fimmu.2017.00086
|
[29]
|
Zhang, Q.W., Liu, L., Gong, C.Y., et al. (2012) Prognostic Significance of Tumor-Associated Macrophages in Solid Tumor: A Meta-Analysis of the Literature. PLOS ONE, 7, e50946. https://doi.org/10.1371/journal.pone.0050946
|
[30]
|
Dai, F., Liu, L., Che, G., et al. (2010) The Number and Microlocalization of Tumor-Associated Immune Cells Are Associated with Patient’s Survival Time in Non-Small Cell Lung Cancer. BMC Cancer, 10, Article No. 220.
https://doi.org/10.1186/1471-2407-10-220
|
[31]
|
Lin, E.Y., Li, J.F., Gnatovskiy, L., et al. (2006) Macrophages Reg-ulate the Angiogenic Switch in a Mouse Model of Breast Cancer. Cancer Research, 66, 11238-11246. https://doi.org/10.1158/0008-5472.CAN-06-1278
|
[32]
|
Sierra, J.R., Corso, S., Caione, L., et al. (2008) Tumor An-giogenesis and Progression Are Enhanced by Sema4D Produced by Tumor-Associated Macrophages. The Journal of Experimental Medicine, 205, 1673-1685.
https://doi.org/10.1084/jem.20072602
|
[33]
|
Lin, L., Chen, Y.S., Yao, Y.D., et al. (2015) CCL18 from Tu-mor-Associated Macrophages Promotes Angiogenesis in Breast Cancer. Oncotarget, 6, 34758-34773. https://doi.org/10.18632/oncotarget.5325
|
[34]
|
Rolny, C,, Mazzone, M., Tugues, S., et al. (2011) HRG Inhibits Tumor Growth and Metastasis by Inducing Macrophage Polarization and Vessel Normalization through Downregulation of PlGF. Cancer Cell, 19, 31-44.
https://doi.org/10.1016/j.ccr.2010.11.009
|
[35]
|
Chen, P., Huang, Y., Bong, R., et al. (2011) Tumor-Associated Macrophages Promote Angiogenesis and Melanoma Growth via Adrenomedullin in a Paracrine and Autocrine Manner. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 17, 7230-7239. https://doi.org/10.1158/1078-0432.CCR-11-1354
|
[36]
|
Guruvayoorappan, C. (2008) Tumor versus Tu-mor-Associated Macrophages: How Hot Is the Link? Integrative Cancer Therapies, 7, 90-95. https://doi.org/10.1177/1534735408319060
|
[37]
|
Deryugina, E.I., Zajac, E., Juncker-Jensen, A., et al. (2014) Tis-sue-Infiltrating Neutrophils Constitute the Major in Vivo Source of Angiogenesis-Inducing MMP-9 in the Tumor Micro-environment. Neoplasia (New York, NY), 16, 771-788.
https://doi.org/10.1016/j.neo.2014.08.013
|
[38]
|
Lewis, C.E., Harney, A.S. and Pollard, J.W. (2016) The Multifac-eted Role of Perivascular Macrophages in Tumors. Cancer Cell, 30, 18-25. https://doi.org/10.1016/j.ccell.2016.05.017
|
[39]
|
Schoppmann, S.F., Birner, P., Stöckl, J., et al. (2002) Tu-mor-Associated Macrophages Express Lymphatic Endothelial Growth Factors and Are Related to Peritumoral Lymphan-giogenesis. The American Journal of Pathology, 161, 947-956.
https://doi.org/10.1016/S0002-9440(10)64255-1
|
[40]
|
Ji, R.C. (2012) Macrophages Are Important Mediators of ei-ther Tumor- or Inflammation-Induced Lymphangiogenesis. Cellular and Molecular Life Sciences: CMLS, 69, 897-914. https://doi.org/10.1007/s00018-011-0848-6
|
[41]
|
Jung, M., Ören, B., Mora, J., et al. (2016) Lipocalin 2 from Mac-rophages Stimulated by Tumor Cell-Derived Sphingosine 1-Phosphate Promotes Lymphangiogenesis and Tumor Metas-tasis. Science Signaling, 9, ra64.
https://doi.org/10.1126/scisignal.aaf3241
|
[42]
|
Cannarile, M.A., Weisser, M., Jacob, W., et al. (2017) Colo-ny-Stimulating Factor 1 Receptor (CSF1R) Inhibitors in Cancer Therapy. Journal for Immunotherapy of Cancer, 5, 53. https://doi.org/10.1186/s40425-017-0257-y
|
[43]
|
Jeong, H., Kim, S., Hong, B.J., et al. (2019) Tumor-Associated Macrophages Enhance Tumor Hypoxia and Aerobic Glycolysis. Cancer Research, 79, 795-806. https://doi.org/10.1158/0008-5472.CAN-18-2545
|
[44]
|
Jeong, S.K., Kim, J.S., Lee, C.G., et al. (2017) Tumor As-sociated Macrophages Provide the Survival Resistance of Tumor Cells to Hypoxic Microenvironmental Condition through IL-6 Receptor-Mediated Signals. Immunobiology, 222, 55-65. https://doi.org/10.1016/j.imbio.2015.11.010
|
[45]
|
Moisan, F., Francisco, E.B., Brozovic, A., et al. (2014) En-hancement of Paclitaxel and Carboplatin Therapies by CCL2 Blockade in Ovarian Cancers. Molecular Oncology, 8, 1231-1239. https://doi.org/10.1016/j.molonc.2014.03.016
|
[46]
|
Wang, R., Zhang, J., Chen, S., et al. (2011) Tu-mor-Associated Macrophages Provide a Suitable Microenvironment for Non-Small Lung Cancer Invasion and Progres-sion. Lung Cancer (Amsterdam, Netherlands), 74, 188-196.
https://doi.org/10.1016/j.lungcan.2011.04.009
|
[47]
|
Almholt, K., Lund, L.R., Rygaard, J., et al. (2005) Reduced Metastasis of Transgenic Mammary Cancer in Urokinase-Deficient Mice. International Journal of Cancer, 113, 525-532. https://doi.org/10.1002/ijc.20631
|
[48]
|
Yan, D., Wang, H.W., Bowman, R.L., et al. (2016) STAT3 and STAT6 Signaling Pathways Synergize to Promote Cathepsin Secretion from Macrophages via IRE1α Activation. Cell Reports, 16, 2914-2927.
https://doi.org/10.1016/j.celrep.2016.08.035
|
[49]
|
Gil-Bernabé, A.M., Ferjancic, S., Tlalka, M., et al. (2012) Re-cruitment of Monocytes/Macrophages by Tissue Factor-Mediated Coagulation Is Essential for Metastatic Cell Survival and Premetastatic Niche Establishment in Mice. Blood, 119, 3164-3175. https://doi.org/10.1182/blood-2011-08-376426
|
[50]
|
Sanford, D.E., Belt, B.A., Panni, R.Z., et al. (2013) Inflam-matory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 19, 3404-3415. https://doi.org/10.1158/1078-0432.CCR-13-0525
|
[51]
|
Bockorny, B., Semenisty, V., Macarulla, T., et al. (2020) BL-8040, a CXCR4 Antagonist, in Combination with Pembrolizumab and Chemotherapy for Pancreatic Cancer: The COMBAT Trial. Nature Medicine, 26, 878-885.
https://doi.org/10.1038/s41591-020-0880-x
|
[52]
|
Markiewski, M.M., Deangelis, R.A., Benencia, F., et al. (2008) Modulation of the Antitumor Immune Response by Complement. Nature Immunology, 9, 1225-1235. https://doi.org/10.1038/ni.1655
|
[53]
|
Yancey, K.B., Lawley, T.J., Dersookian, M., et al. (1989) Analysis of the In-teraction of Human C5a and C5a des Arg with Human Monocytes and Neutrophils: Flow Cytometric and Chemotaxis Studies. The Journal of Investigative Dermatology, 92, 184-189. https://doi.org/10.1111/1523-1747.ep12276710
|
[54]
|
Corrales, L., Ajona, D., Rafail, S., et al. (2012) Anaphylatoxin C5a Creates a Favorable Microenvironment for Lung Cancer Progression. Journal of Immunology (Baltimore, Md: 1950), 189, 4674-4683.
https://doi.org/10.4049/jimmunol.1201654
|
[55]
|
Janson, C., Jung, H., Ertl, L., et al. (2017) Inhibition of CCR2 Po-tentiates Checkpoint Inhibitor Immunotherapy in Murine Model of Pancreatic Cancer. Cancer Research, 77. https://doi.org/10.1158/1538-7445.AM2017-5655
|
[56]
|
Kumar, V., Donthireddy, L., Marvel, D., et al. (2017) Cancer-Associated Fibroblasts Neutralize the Anti-Tumor Effect of CSF1 Receptor Blockade by Inducing PMN-MDSC Infiltration of Tumors. Cancer Cell, 32, 654-668.e5.
https://doi.org/10.1016/j.ccell.2017.10.005
|
[57]
|
Comito, G., Pons Segura, C., Taddei, M.L., et al. (2017) Zoledronic Acid Impairs Stromal Reactivity by Inhibiting M2-Macrophages Polarization and Prostate Cancer-Associated Fibroblasts. Oncotarget, 8, 118-132.
https://doi.org/10.18632/oncotarget.9497
|
[58]
|
Wu, X., Schulte, B.C., Zhou, Y., et al. (2014) Depletion of M2-Like Tumor-Associated Macrophages Delays Cutaneous T-Cell Lymphoma Development in Vivo. The Journal of Investigative Dermatology, 134, 2814-2822.
https://doi.org/10.1038/jid.2014.206
|
[59]
|
Zhang, W., Zhu, X.D., Sun, H.C., et al. (2010) Depletion of Tu-mor-Associated Macrophages Enhances the Effect of Sorafenib in Metastatic Liver Cancer Models by Antimetastatic and Antiangiogenic Effects. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 16, 3420-3430.
https://doi.org/10.1158/1078-0432.CCR-09-2904
|
[60]
|
Germano, G., Frapolli, R., Belgiovine, C., et al. (2013) Role of Macrophage Targeting in the Antitumor Activity of Trabectedin. Cancer Cell, 23, 249-262. https://doi.org/10.1016/j.ccr.2013.01.008
|
[61]
|
Liguori, M., Buracchi, C., Pasqualini, F., et al. (2016) Functional TRAIL Receptors in Monocytes and Tumor-Associated Macrophages: A Possible Targeting Pathway in the Tumor Mi-croenvironment. Oncotarget, 7, 41662-41676.
https://doi.org/10.18632/oncotarget.9340
|
[62]
|
La Fleur, L., Botling, J., He, F., et al. (2021) Targeting MARCO and IL37R on Immunosuppressive Macrophages in Lung Cancer Blocks Regulatory T Cells and Supports Cytotoxic Lym-phocyte Function. Cancer Research, 81, 956-967.
https://doi.org/10.1158/0008-5472.CAN-20-1885
|
[63]
|
Mantovani, A., Marchesi, F., Malesci, A., et al. (2017) Tumour-Associated Macrophages as Treatment Targets in Oncology. Nature Reviews Clinical Oncology, 14, 399-416. https://doi.org/10.1038/nrclinonc.2016.217
|
[64]
|
Gallotta, M., Assi, H., Degagné, É., et al. (2018) Inhaled TLR9 Agonist Renders Lung Tumors Permissive to PD-1 Blockade by Promoting Optimal CD4 and CD8 T-Cell Interplay. Cancer Research, 78, 4943-4956.
https://doi.org/10.1158/0008-5472.CAN-18-0729
|
[65]
|
Karapetyan, L., Luke, J.J. and Davar, D. (2020) Toll-Like Receptor 9 Agonists in Cancer. OncoTargets and Therapy, 2020, 10039-10061. https://doi.org/10.2147/OTT.S247050
|
[66]
|
Kaneda, M.M., Messer, K.S., Ralainirina, N., et al. (2017) Corrigen-dum: PI3Kγ Is a Molecular Switch That Controls Immune Suppression. Nature, 542, 124. https://doi.org/10.1038/nature21026
|
[67]
|
Mirzaei, S., Gholami, M.H., Mahabady, M.K., et al. (2021) Pre-Clinical Investigation of STAT3 Pathway in Bladder Cancer: Paving the Way for Clinical Translation. Biomedicine & Pharma-cotherapy, 133, Article ID: 111077.
https://doi.org/10.1016/j.biopha.2020.111077
|
[68]
|
Chen, Y.H., Zhou, B.Y., Wu, G.C., et al. (2018) Effects of Ex-ogenous IL-37 on the Biological Characteristics of Human Lung Adenocarcinoma A549 Cells and the Chemotaxis of Regulatory T Cells. Cancer Biomarkers: Section A of Disease Markers, 21, 661-673. https://doi.org/10.3233/CBM-170732
|
[69]
|
Zhang, Z., Zhang, J., He, P., et al. (2020) Interleukin-37 Suppresses Hepatocellular Carcinoma Growth through Inhibiting M2 Polarization of Tumor-Associated Macrophages. Molecular Immunology, 122, 13-20.
https://doi.org/10.1016/j.molimm.2020.03.012
|
[70]
|
Chen, Y., Jin, H., Song, Y., et al. (2021) Targeting Tu-mor-Associated Macrophages: A Potential Treatment for Solid Tumors. Journal of Cellular Physiology, 236, 3445-3465. https://doi.org/10.1002/jcp.30139
|